Biotechnology company Humacyte, Inc. announces exclusive distribution rights for the innovative medical device Symvess outside the United States.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to the terms of the agreement, medical giant Fresenius will receive a low single-digit percentage royalty from the net sales of this product. This collaboration will strengthen Humacyte's commercial presence in the global vascular repair sector, while also providing Fresenius with a continuous revenue stream.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Alcoa (AA.US) reported third-quarter revenue of $3.7 billion, up nearly 24% year-on-year.
Alcoa reported its financial results for the third quarter of 2026 on Thursday, showing a revenue of 3.704 billion USD for the quarter.
智通财经•2026/10/15 22:36
Crypto prices
More
Bitcoin
BTC
$82,393.68
+1.02%
Ethereum
ETH
$2,454.22
+1.54%
Tether USDt
USDT
$0.9989
+0.02%
BNB
BNB
$729.76
+0.33%
XRP
XRP
$1.34
+0.53%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$105.76
+1.22%
TRON
TRX
$0.3321
+0.07%
Hyperliquid
HYPE
$82.24
+1.86%
Zcash
ZEC
$1,233.41
+7.97%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now